Tetrathiomolybdate protects against liver injury from acetaminophen in mice

Journal of Applied Research

Volumn 4, Issue 3, 2004, Pages 419-426

  Ma, Shaochun ^a   Hou, Guoqing ^a   Dick, Robert ^a   Brewer, George J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acetaminophen; Amino leucine transaminase; Ceruloplasmin; Copper; Hepatotoxicity; Tetrathiomolybdate

Indexed keywords

BLEOMYCIN; CARBON TETRACHLORIDE; CERULOPLASMIN; CONCANAVALIN A; COPPER; CYTOKINE; PARACETAMOL; TETRATHIOMOLYBDIC ACID;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INTOXICATION; DRUG MECHANISM; FEMALE; LIVER FAILURE; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; LUNG INJURY; MOUSE; NONHUMAN; WILSON DISEASE;

EID: 4644266563     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lee WM. Acute liver failure in the United States. Seminars In Liver Disease. 2003;23:217-226.
2. Gyamlani GG, Parikh CR. Acetaminophen toxicity: suicidal vs. accidental. Crit Care. 2002;6:155-159.
3. Kozer E, McGuigan M. Treatment strategies for early presenting acetaminophen overdose: a survey of medical directors of poison centers in North America and Europe. Hum Exp Toxicol. 2002;21:123-127.
4. Askari FK, Dick RB, Mao M, Brewer GJ. Tetrathiomolybdate therapy protects against concanavalin A and carbon tetrachloride hepatic damage in mice. Exp Biol Med. In press.
5. Brewer GJ, Ullenbruch MR, Dick R, Olivarez L, Phan SH. Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice. J Lab Clin Med. 2003;141:210-216.
6. Brewer GJ, Dick RD, Yuzbasiyan-Gurkin V, Tankanow R, Young AB, Kluin KJ. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol. 1991;48:42-47.
7. Brewer GJ, Dick RD, Johnson V, et al. Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch Neurol. 1994;51:545-554.
8. Brewer GJ, Johnson V, Dick RD, Kluin KJ, Fink JK, Brunberg JA. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 1996;53:1017-1025.
9. Brewer GJ, Hedera P, Kluin KJ, Carlson MD, Askari F, Dick RD, Sitterly JA, Fink JK. Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 2003;60:379-385.
10. Cox C, Teknos TN, Barrios M, Brewer GJ, Dick RD, Merajver SD. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope. 2001;111:696-701.
11. Khan MK, Miller MW,Taylor J, et al. Radiotherapy and antiangiogenic TM in lung cancer. Neoplasia. 2002;4:164-170.
12. Pan Q, Kleer C, van Golen K, Irani J, Bottema KM, Bias C, De Carvalho MD, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002;62:4854-4859.
13. van Golen KL, Bao L, Brewer GJ, Pienta K, Karadt J, Livant D, Merajver SD. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia. 2002;4:373-379.
14. Kent MS, Madewell BR, Dank G, Dick RD, Merajver SD, Brewer GJ. An anticopper antiangiogenic approach for advanced cancer in spontaneously occurring tumors, using tetrathiomolybdate: A pilot study in a canine animal mode. J Trace Elements Exp Med. 2004;17:9-20.
15. Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, Pienta K, Redman BG, Thierry J, Sondak VK, Strawderman M, LeCarpentier G, Merajver SD. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study, Clin Cancer Res. 2000;6:1-10.
16. Knight TR, Ho YS, Farhood A, Jaeschke H. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther. 2002;303:468-475.
17. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sciences. 2002;65:166-176.
18. Gooneratne SR, Howell JM, Gawthorne JM. Intravenous administration of thiomolybdate for the prevention and treatment of chronic copper poisoning in sheep. Brit J Nutr. 1981;46:457-467.
19. Humphries WR, Mills CF, Greig A, Roberts L, Inglis D, Halliday GJ. Use of ammonium tetrathiomolybdate in the treatment of copper poisoning in sheep. Veterinary Rec. 1986;119:596-598.
20. Humphries WR, Morrice PC, Bremner I. A convenient method for the treatment of chronic copper poisoning in sheep using subcutaneous ammonium tetrathiomolybdate. Veterinary Rec. 1988;123:51-53.